Dietary supplement for radiation-related rectal injury
Part of Digestive system clinical trials.
This trial tests a dietary supplement to help heal damage inside the rectum caused by pelvic radiation therapy. If you have mild to moderate rectal bleeding but no signs of cancer recurrence, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You finished pelvic radiation therapy at least 3 months ago and your cancer has not returned or spread.
- You have rectal bleeding that is mild to moderate (grade 1-2).
- You do not have serious infections, bleeding problems, or bowel blockages.
- You have not had rectal surgery or have large ulcers, fistulas, or narrowing in your rectum.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of a special diet supplement (beta-hydroxybutyrate), short radiation therapy, immunotherapy, and chemotherapy before surgery for locally advanced rectal cancer. The goal is to see if this approach helps shrink the tumor and improve treatment outcomes.
This trial tests whether a special kind of stem cell (called TH-SC01) can help people with long-term rectal damage from pelvic radiation. You will be injected with a small amount of radioactive material attached to the cells so doctors can see where they go and how long they stay in your body.
This trial tests a shorter course of radiation that avoids draining lymph nodes, followed by an immunotherapy drug (PD-1 inhibitor), for people with stage II or III rectal cancer that is mismatch repair proficient (pMMR) or microsatellite stable (MSS). The goal is to see if this approach can shrink tumors while keeping lymph nodes intact.
This study tests whether a fecal (stool) transplant can help heal rectal damage caused by pelvic radiation. The treatment may decrease bleeding and improve symptoms for people whose supportive care hasn't worked well.
This trial tests whether a Bergmann enema can help prevent radiation-related rectal injury during short-course radiotherapy for rectal cancer. It may be an option for people who are about to start pelvic radiation.
This trial tests whether a steroid enema (dexamethasone) can help prevent or reduce bowel damage caused by radiation therapy for rectal cancer. If you're starting or recently started radiation for rectal cancer, this may help protect your bowel health.
Hear when a new Radiotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.